GAO report criticizes Part D procedures
Not only have CMS' procedures created problems for dual-eligibles attempting to find a prescription drug plan, but the report notes that pharmacies may be affected adversely when "key information about a beneficiary's dual eligibility is not yet processed and available."
CMS' enrollment procedures and implementation of the Medicare Part D program for dual-eligibles has created "challenges for some dual-eligible beneficiaries, pharmacies, and the Medicare program," according to a report issued by GAO. Not only have CMS' procedures created problems for dual-eligibles attempting to find a prescription drug plan, but the report notes that pharmacies may be affected adversely when "key information about a beneficiary's dual eligibility is not yet processed and available." The report offered a series of recommendations for CMS, including improving communication with dual-eligible beneficiaries and fostering better data sharing between drug plans and the states. That lack of communication may have cost more than 400,000 dual-eligible beneficiaries some federal subsidies. In response, CMS insisted that it has already taken steps to improve notification to dual-eligibles and objected to the "overwhelmingly negative tone to the findings."
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
